Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Progress in Brain Research
|
October 22, 2008
Clinical trials in neuroprotection
Scott M Whitcup
International Ophthalmology Clinics
|
October 25, 2006
Recent advances in ocular therapeutics
Scott M Whitcup
Handbook of Experimental Pharmacology
|
August 28, 2019
The History of Botulinum Toxins in Medicine: A Thousand Year Journey
Scott M Whitcup
Expert Review of Clinical Pharmacology
|
December 14, 2012
Pharmacologic and clinical profile of dexamethasone intravitreal implant
Michael R Robinson, Scott M Whitcup
Annals of the New York Academy of Sciences
|
July 23, 2015
Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis
Scott M Whitcup, Michael R Robinson
Survey of Ophthalmology
|
March 16, 2004
A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure
Neil Choplin, Paula Bernstein, Amy L Batoosingh, et al.
Ophthalmology
|
December 4, 2003
A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension
Anne L Coleman, Fabian Lerner, Paula Bernstein, et al.
Investigative Ophthalmology & Visual Science
|
January 4, 2018
Pharmacology of Corticosteroids for Diabetic Macular Edema
Scott M Whitcup, John A Cidlowski, Karl G Csaky, et al.
Obesity (Silver Spring, Md.)
|
May 3, 2013
LAP-BAND for lower BMI: 2-year results from the multicenter pivotal study
Robert Michaelson, Diane K Murphy, Todd M Gross, et al.
Annals of the New York Academy of Sciences
|
November 18, 2014
Development of onabotulinumtoxinA for chronic migraine
Scott M Whitcup, Catherine C Turkel, Ronald E DeGryse, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Progress in Brain Research
|
October 22, 2008
Clinical trials in neuroprotection
Scott M Whitcup
International Ophthalmology Clinics
|
October 25, 2006
Recent advances in ocular therapeutics
Scott M Whitcup
Handbook of Experimental Pharmacology
|
August 28, 2019
The History of Botulinum Toxins in Medicine: A Thousand Year Journey
Scott M Whitcup
Expert Review of Clinical Pharmacology
|
December 14, 2012
Pharmacologic and clinical profile of dexamethasone intravitreal implant
Michael R Robinson, Scott M Whitcup
Annals of the New York Academy of Sciences
|
July 23, 2015
Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis
Scott M Whitcup, Michael R Robinson
Survey of Ophthalmology
|
March 16, 2004
A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure
Neil Choplin, Paula Bernstein, Amy L Batoosingh, et al.
Ophthalmology
|
December 4, 2003
A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension
Anne L Coleman, Fabian Lerner, Paula Bernstein, et al.
Investigative Ophthalmology & Visual Science
|
January 4, 2018
Pharmacology of Corticosteroids for Diabetic Macular Edema
Scott M Whitcup, John A Cidlowski, Karl G Csaky, et al.
Obesity (Silver Spring, Md.)
|
May 3, 2013
LAP-BAND for lower BMI: 2-year results from the multicenter pivotal study
Robert Michaelson, Diane K Murphy, Todd M Gross, et al.
Annals of the New York Academy of Sciences
|
November 18, 2014
Development of onabotulinumtoxinA for chronic migraine
Scott M Whitcup, Catherine C Turkel, Ronald E DeGryse, et al.
Page
of 7